NCT07744997
Radicle RestTM VGI: A Study Assessing the Impact of Health and Wellness Products Gene III® L-Ergothioneine Capsules and Gene III® L-Ergothioneine on Sleep and Related Health Outcomes
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 17 words Show 4 more changesShow less
- Trial completed
- Final enrollment: 500 participants (planned 600)
- Primary completion date changed from estimate of Aug 6, 2027 to Nov 5, 2026
- Study title expanded, about 8 words
- Minor Enrollment closed, study ongoing
- Start date changed from estimate of Aug 6, 2026 to Aug 11, 2026
- Site details revised
- Notable Recruitment opened
- Site details revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Change in sleep
Timeframe: 7 weeks
Secondary (3)
Change in sleep-related impairment
Change in mood (emotional distress-depression)
Change in fatigue
Arms and interventions
Active Rest Product 1Experimental
Active Rest Product 1
Placebo Rest ControlPlacebo comparator
Placebo Rest Control
Dietary supplements: Placebo Rest Control, Active Rest Product 1
Sites
1 site in 1 country
- Radicle Science Inc.Del Mar, California, United States